David Nusbaum, MD on Phase I Trial: Autologous TIL Therapy for BCG-Exposed Bladder Cancer
Автор: Moffitt Cancer Center
Загружено: 2025-11-07
Просмотров: 28
Join David Nusbaum, MD at #SITC25 as he shares the findings of a phase I clinical trial of intravesical therapy with autologous TIL in BCG-exposed non-muscle invasive bladder cancer. Nearly half of patients enrolled in the trial responded to the cellular immunotherapy.
Read more: https://moffitt.org/endeavor/archive/...
#MoffittSITC25
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: